Piper Sandler Reiterates Overweight on Nutanix, Raises Price Target to $75
Piper Sandler analyst James Fish reiterates Nutanix (NASDAQ:NTNX) with a Overweight and raises the price target from $60 to $75.
Read original at benzingaStocks · News reference
Nutanix Sees FY2027 Sales $3.180B-$3.230B vs $3.191B Est
Nutanix (NASDAQ:NTNX) sees FY2027 sales of $3.180 billion-$3.230 billion vs $3.191 billion analyst estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 26, 2026, 8:08 PM
- Checked
- Aug 26, 2026, 8:08 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why Nutanix Stock Is Soaring Today
Nutanix stock surged 9.87% after reporting Q4 2026 results that beat analyst expectations with $757.1 million in revenue (16% YoY growth) and $0.60 diluted EPS versus $0.49 expected. The company also generated strong free cash flow of $277.6 million and provided optimistic fiscal 2027 guidance of $3.18-$3.23 billion in revenue and $850-$950 million in free cash flow.
Read original at the-motley-foolRBC Capital Maintains Outperform on Nutanix, Raises Price Target to $90
RBC Capital analyst Matthew Hedberg maintains Nutanix (NASDAQ:NTNX) with a Outperform and raises the price target from $84 to $90.
Read original at benzingaSynopsys Posts Upbeat Q3 Results, Joins Okta, Veeva Systems, Crowdstrike And Other Big Stocks Moving Higher On Thursday
U.S. stocks mostly higher, Nasdaq up 1%. Synopsys Inc. reports strong Q3 results and raises outlook. Other gainers include Okta, Veeva, Salesforce, Ooma, Crowdstrike, Sailpoint, Hyperliquid, Tenable, Palo Alto Networks, and Zscaler.
Read original at benzinga